Compare BridgeBio Pharma Inc (BBIO) vs GameStop Corp. (GME) Price & Performance

BridgeBio Pharma IncTrade

GameStop Corp.Trade

Price performance (Past 24H)

Key statistics

BridgeBio Pharma Inc vs GameStop Corp. — how do they compare? BridgeBio Pharma Inc trades at $83.9 (market cap $16.61B), while GameStop Corp. trades at $18.82 (market cap $8.60B). The key difference: BridgeBio Pharma Inc is the larger of the two by market cap, and BridgeBio Pharma Inc is trading nearer its 52-week high, GameStop Corp. nearer its low. Which is the better fit depends on your goals.

	BBIO	GME
Market Cap	$16.61B	$8.60B
Sector	Health	Consumer Cyclical
52-Week High	$90.17	$27.69
52-Week Low	$47.29	$18.79
Enterprise Value	$18.16B	$4.57B

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

BBIO

BridgeBio beats Q2 estimates, confirms $1B+ 2026 sales goal and plans three product launches by 2027.Seeking Alpha · 20 hours agoBullish View details →

GME

GameStop upgraded to 'Buy' as revenue, profits, and cash flow improve significantly in collectibles business.Seeking Alpha · 1 day agoBullish GameStop CEO may drop $56B eBay takeover bid, eyeing partnership insteadNew York Post · 1 day agoBearish GameStop may drop $56B eBay buy, opts for partnership to boost collectibles market.PYMNTS · 1 day agoNeutral View details →

About BridgeBio Pharma Inc

BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.

About GameStop Corp.

Global Market Group Ltd. operates an Internet website that connects Chinese manufacturers with international buyers. The Company's customers can post company profiles and product information in standardized formats; post product listings; and trade leads.